Dr. Amy Michelle Kritzer, MD

Dr. Kritzer practices at Boston Children's Hospital in Boston, Massachusetts, part of The Children's Hospital.

Dr. Kritzer's NPI, 1700044336, was assigned on May 30, 2008. Dr. Kritzer graduated from Albert Einstein College of Medicine in 2004. Dr. Kritzer holds Massachusetts license 254424.

Dr. Kritzer's primary practice is Boston Children's Hospital, at 300 Longwood Avenue, Boston, MA 02115 in Suffolk County. The practice phone is (617) 735-6000.

Dr. Kritzer's primary practice is Boston Children's Hospital in Boston, Massachusetts, part of The Children's Hospital. Dr. Kritzer is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Dartmouth Hitchcock Clinics Manchester. Dmand AI also links Dr. Kritzer to 2 more medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kritzer practices, 3 sites in all. Vendor and product names are available with a free account.

Clinical genetics (m.d.) is Dr. Kritzer's primary specialty in the NPI Registry, under taxonomy code 207SG0201X. Dr. Kritzer is board certified in clinical genetics and genomics by the American Board of Medical Genetics and Genomics. Dmand AI has Dr. Kritzer's licenses on file in 4 states: Massachusetts, New Hampshire, Vermont and Texas.

CMS counts 14 Medicare patients who saw Dr. Kritzer in 2024. The largest group is 75 to 84, with 0 patients. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kritzer's median patient age at 13, with 52% women.

In 2024, Dr. Kritzer wrote 35 Medicare Part D claims. 0% of them were for generic drugs. They cover 2 drugs, with $948,640 in total drug cost. In 2023, CMS named 36 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Kritzer for performance year 2024, reported through an alternative payment model (APM). Dr. Kritzer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kritzer as offering telehealth.

Dmand AI links 31 papers to Dr. Kritzer, published from 2017 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Phenotype, Neurodevelopmental Disorders and Amino Acid Metabolism, Inborn Errors. Dr. Kritzer has published most often in Mol Genet Metab Rep. Dr. Kritzer's most frequent co-authors are Daniel Calame, MD, Pankaj B. Agrawal, MD and James Lupski, MD, PhD.

Dmand AI links Dr. Kritzer to 1 clinical trial. Conditions studied include Mucopolysaccharidosis IV and Mucopolysaccharidoses.

CMS Open Payments shows 20 general payments to Dr. Kritzer from 3 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 49% of the total. Sanofi and Genzyme US Companies paid the most, $6,939.

Dr. Kritzer graduated from Albert Einstein College of Medicine in 2004.

Dr. Kritzer is in network with 10 carriers, including Aetna, United Healthcare and Elevance. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.